Shanghai Labway Clinical Laboratory Co. Ltd. announced that at the AGM was held on 26 May 2023, the company approved cash dividend/10 shares (tax included): CNY 3.0000000 for 2022.
Shanghai Labway Clinical Laboratory Co., Ltd
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.77 CNY | -0.20% | +8.19% | -26.49% |
1st Jan change | Capi. | |
---|---|---|
-26.49% | 540M | |
-16.58% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-6.85% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-14.57% | 1.03B |
- Stock Market
- Equities
- 301060 Stock
- News Shanghai Labway Clinical Laboratory Co., Ltd
- Shanghai Labway Clinical Laboratory Co., Ltd Approves Cash Dividend for 2022